Brian K. Link

University of Iowa — United States

Medicine · Health Sciences

71h-index23.9kcitations620works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(473), Chronic Lymphocytic Leukemia Research(217), Viral-associated cancers and disorders(92), Monoclonal and Polyclonal Antibodies Research(73), CNS Lymphoma Diagnosis and Treatment(63)

Publications617 total

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Blood Advances·2025Open Access
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma
Journal of Clinical Oncology·2025Open Access
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
Nature Communications·2025· 1 citedOpen Access
FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting
Blood·2025Open Access
Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)
Blood·2025Open Access
Outcomes in the 2nd decade following follicular lymphoma (FL) diagnosis: Long-term follow-up from the university of Iowa/Mayo Clinic SPORE molecular epidemiology resource (MER)
Blood·2025Open Access
External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials
Blood·2025Open Access
Bioflipi scores define distinct immune profiles in follicular lymphoma
Blood·2025
PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course
Blood·2025
Survival differences in metropolitan versus nonmetropolitan/rural counties in the US: An analysis according to rural-urban continuum codes (RUCC) in the lymphoma epidemiology of outcomes (LEO) study cohort
Blood·2025
Adaptation and Performance of the Self‐Report‐Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
Hematological Oncology·2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Blood Advances·2025· 1 citedOpen Access
Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses
International Journal of Cancer·2025Open Access
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
Blood Cancer Journal·2025Open Access
Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study
Leukemia & lymphoma/Leukemia and lymphoma·2025Open Access
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
Blood Cancer Journal·2025· 2 citedOpen Access
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
2025Open Access
307 | IMPACT OF CELL OF ORIGIN, GENE REARRANGEMENTS, FRONTLINE TREATMENT ON INCIDENCE OF CENTRAL NERVOUS SYSTEM LYMPHOMA RELAPSE IN NEWLY DIAGNOSED LARGE B‐CELL LYMPHOMA
Hematological Oncology·2025Open Access
29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA
Hematological Oncology·2025Open Access
233 | S1608: RANDOMIZED PHASE II TRIAL COMPARING LENALIDOMIDE/OBINUTUZUMAB AND UMBRALISIB/OBINUTUZUMAB WITH CHEMOIMMUNOTHERAPY IN EARLY PROGRESSING FOLLICULAR LYMPHOMA (POD24)
Hematological Oncology·2025Open Access
page 1 of 31Next →

Frequent Co-authors

James R. Cerhan(22), George J. Weiner(16), Matthew J. Maurer(14), Thomas M. Habermann(12), Susan L. Slager(11), Stephen M. Ansell(11), Thomas E. Witzig(11), Carrie A. Thompson(9), Andrew L. Feldman(8), Christopher R. Flowers(7), Andrew D. Zelenetz(7), Jonathan W. Friedberg(7), Hervé Ghesquières(7), Cristine Allmer(7), Gilles Salles(7), Grzegorz S. Nowakowski(7), Anne J. Novak(6), David J. Inwards(6), A.J. Grillo-López(5), Ronald Levy(5)